With the in vitro activity and cell penetration of optimized RFP stapled peptides confirmed, we next sought to determine whether RFP-mediated disruption of RAB25:FIP complexes would antagonize RAB25-mediated phenotypes in cancer cells. This evidence concerns the gene RAB25 and cancer.